HbA1c Fast Test Kit - India CDSCO Medical Device Registration

HbA1c Fast Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000153_00759a67a58bd21c8ce82a60e2697668_6f07c9194c0e51840a1f0dc29b9fc30a. This device is marketed under the brand name Immunofluorescence Assay. The license holder is Cipla Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

HbA1c Fast Test Kit

UID: IMP/IVD/2022/000153_00759a67a58bd21c8ce82a60e2697668_6f07c9194c0e51840a1f0dc29b9fc30a

Brand Name

Immunofluorescence Assay

License Holder

Cipla Limited

Device Class

Class B

Approving Authority

CDSCO

Product Information

HbA1c fast test kit is intended for the quantitative measurement of HbA1c in human whole blood samples. This test is used as an aid for monitoring glycemic control in diabetics. In addition, it can identify people at risk of developing the disease and ongoing monitoring